FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "SCA Pharmaceuticals, LLC(080545245)" | Vancomycin Hydrochloride | 1 g/250 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Vancomycin Hydrochloride | 1.25 g/250 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Vancomycin Hydrochloride | 1.5 g/250 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Vancomycin Hydrochloride | 2 g/500 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | "potassium Phosphate, Dibasic; Potassium Phosphate, Monobasic" | 15 mmol/250 mL; 15 mmol/250 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Diltiazem Hydrochloride | 1 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Diltiazem Hydrochloride | 1 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Ephedrine Sulfate | 10 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Ephedrine Sulfate | 5 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Ephedrine Sulfate | 5 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate | .05 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate | .02 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate | .01 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate | .01 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate | .01 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; .625 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .005 mg/1 mL; 4 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate; Ropivacaine Hydrochloride | .002 mg/1 mL; 1 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate; Ropivacaine Hydrochloride | .002 mg/1 mL; 2 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Hydromorphone Hydrochloride | .2 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Hydromorphone Hydrochloride | .2 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Hydromorphone Hydrochloride | 1 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Hydromorphone Hydrochloride | 1 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Ketamine Hydrochloride | 10 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Ketamine Hydrochloride | 50 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Labetalol Hydrochloride | 5 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Lidocaine Hydrochloride | 20 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Lidocaine Hydrochloride | 10 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Methadone Hydrochloride | 10 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Norepinephrine Bitartrate | .032 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Norepinephrine Bitartrate | .064 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Oxytocin | 30 U/500 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "STAQ Pharma of Ohio, LLC(118684089)" | Phenylephrine Hydrochloride | 100 ug/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "STAQ Pharma of Ohio, LLC(118684089)" | Sodium Chloride | 9 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "STAQ Pharma of Ohio, LLC(118684089)" | Succinylcholine Chloride | 20 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "STAQ Pharma of Ohio, LLC(118684089)" | Succinylcholine Chloride | 20 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "STAQ Pharma of Ohio, LLC(118684089)" | Dexmedetomidine Hydrochloride | 4 ug/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "STAQ Pharma of Ohio, LLC(118684089)" | Lidocaine Hydrochloride | 20 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "STAQ Pharma of Ohio, LLC(118684089)" | Methotrexate | 25 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "STASKA PHARMACEUTICALS, INC.(099939403)" | Thiamine Hydrochloride; Niacinamide | 100 mg/1 mL; 100 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "STASKA PHARMACEUTICALS, INC.(099939403)" | Glutathione | 200 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "STASKA PHARMACEUTICALS, INC.(099939403)" | 80098-030 | 80098-030-90 | Isosulfan Blue | 10 mg/1 mL | 2025-2 | valid | 2026-10-06 | ||
| "STASKA PHARMACEUTICALS, INC.(099939403)" | Ascorbic Acid | 500 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "STASKA PHARMACEUTICALS, INC.(099939403)" | Ascorbic Acid | 500 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "STASKA PHARMACEUTICALS, INC.(099939403)" | Methylcobalamin | 5 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "Wells Pharmacy, Inc(057193721)" | 70713-036 | 70713-036-01 | Progesterone | 50 mg | 2025-2 | valid | 2026-10-06 |